Nicox extends cash runway into next-year reporting
Unaudited estimate by management says cash runway has been extended. Next reporting is the first half 2026 accounts in October 2026, with PDUFA dates described as FDA target completion timelines.
1 Unaudited estimate prepared by management based on information available as of the date of this press release.
The Company’s next reporting will be the first half 2026 accounts in October 2026.2 A PDUFA date is the target date by which the U.S.
Food and Drug Administration (FDA) aims to complete…